GOLDENWELL BIOTECH, INC. (GWLL)
Q3-CY2026Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014
Balance Sheet Date2026-Mar-312025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-312020-Dec-312020-Sep-30
Fiscal PeriodQ1-FY2026Q4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021Q4-FY2020Q3-FY2020
Total Assets18,754$36,120$233,760$267,315$191,915$224,192$179,432$200,398$198,968$228,094$186,933$192,339$219,422$248,400$266,077$274,400$308,686$460,979$485,847$509,176$435,179$248,569$250,544$246,593$
Total Current Assets250,544$246,593$
Cash and Cash Equivalents25,720$53,231$45,996$42,864$67,901$213,556$232,929$245,435$248,569$248,569$250,544$251,422$251,564$246,593$0$
Receivables
Other Current Assets
Assets Held for Sale in Short Term
Total Noncurrent Assets18,754$36,120$233,760$267,315$191,915$224,192$179,432$200,398$198,968$228,094$186,933$192,339$219,422$248,400$266,077$274,400$308,686$460,979$485,847$509,176$435,179$248,569$0$0$
Goodwill
Other Intangible Assets0$0$
Physical Assets
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities380,073$379,833$377,733$383,393$277,693$271,433$198,671$196,571$145,222$143,837$81,410$51,410$51,410$46,782$29,126$32,866$40,352$159,266$154,594$160,166$62,586$0$0$0$
Total Current Liabilities100,000$101,860$101,860$109,620$1,860$29,126$32,866$40,352$159,266$126,000$0$0$0$0$0$
Accounts Payable0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$111,488$103,125$103,125$0$
Short Term Debt
Short Term Capital Lease Obligations0$0$0$0$0$0$25,372$29,126$32,866$40,352$47,779$22,875$22,816$17,069$0$
Other Current Liabilities
Total Noncurrent Liabilities280,073$277,973$275,873$273,773$277,693$269,573$198,671$196,571$145,222$143,837$81,410$51,410$51,410$46,782$0$0$0$0$28,594$160,166$62,586$0$0$0$
Long Term Debt176,085$173,985$46,335$
Long Term Capital Lease Obligations0$28,594$34,225$45,517$0$
Other Noncurrent Liabilities189,250$189,250$189,250$189,250$189,250$189,250$70,000$
Total Equity(361,319$)(343,713$)(143,974$)(116,079$)(85,778$)(47,241$)(20,905$)3,360$53,280$84,257$105,522$140,929$168,012$201,618$236,950$241,533$268,334$301,713$331,254$349,010$372,594$248,569$250,544$251,422$251,564$246,593$0$
Equity to Minority
Equity to Common Shareholders(361,319$)(343,713$)(143,974$)(116,079$)(85,778$)(47,241$)(20,905$)3,360$53,280$84,257$105,522$140,929$168,012$201,618$236,950$241,533$268,334$301,713$331,254$349,010$372,594$248,569$250,544$251,422$251,564$246,593$0$
Additional Paid-In Capital1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$1,302,504$417,804$417,804$417,804$417,804$417,804$417,804$417,804$326,354$248,504$248,504$
Retained Earnings(1,673,722$)(1,656,117$)(1,456,377$)(1,428,481$)(1,398,181$)(1,359,645$)(1,331,643$)(1,308,578$)(1,258,658$)(1,228,147$)(1,206,881$)(1,171,475$)(1,144,392$)(1,110,786$)(190,454$)(185,870$)(159,070$)(125,690$)(96,150$)(78,394$)(54,810$)(8,635$)(5,660$)(2,311$)
Treasury Stock
Capital Lease Obligations